Alamuri, Anusha
Kumar, K. Vinod
SowjanyaKumari, S.
Linshamol, L.
Sridevi, R.
Nagalingam, M.
Roy, Parimal
Balamurugan, V. http://orcid.org/0000-0001-7821-7427
Funding for this research was provided by:
Indian Council of Medical Research (F.No. Leptos/7/2013-EID-1 and ECD/ADHOC/27/2016-17)
Article History
Accepted: 24 September 2020
First Online: 2 October 2020
Compliance with Ethical Standards
:
: The authors declare that they have no competing interests.
: The manuscript does not contain animal experimental trials. This work was carried out in the Institutional Biosafety Committee (IBSC) approved ICMR Project āDevelopment of recombinant antigen-based diagnostics for bovine and human Leptospirosisā (F.No. 6-52/NIVEDI/Biosafety/2016/07-19 dated 11.12.2017). The animal sera including human samples available in the <i>Leptospira</i> Laboratory were used in this study. The leptospirosis suspected human samples from the District surveillance unit, Udupi district, Karnataka, India, and the animal sera from various disease investigation units of the state animal husbandry departments or various veterinary colleges and institutes of India were submitted to the ICAR-NIVEDI or collected by NIVEDI teams for screening by MAT for diagnosis.